| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1984PNAS...81.7632D |
| P356 | DOI | 10.1073/PNAS.81.23.7632 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC392202 |
| https://europepmc.org/articles/PMC392202?pdf=render | ||
| https://pnas.org/doi/pdf/10.1073/pnas.81.23.7632 | ||
| P932 | PMC publication ID | 392202 |
| P698 | PubMed publication ID | 6209719 |
| P5875 | ResearchGate publication ID | 16985988 |
| P50 | author | Elliott D. Kieff | Q43399614 |
| P2093 | author name string | K. Hennessy | |
| E. Kieff | |||
| T. Dambaugh | |||
| L. Chamnankit | |||
| P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
| 57 Sequencing end-labeled DNA with base-specific chemical cleavages | Q27860479 | ||
| Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing | Q27860486 | ||
| Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs | Q27860573 | ||
| A catalogue of splice junction sequences | Q27860696 | ||
| “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A | Q28131712 | ||
| Rapid similarity searches of nucleic acid and protein data banks | Q28270448 | ||
| A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments | Q29618189 | ||
| Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli. | Q30452292 | ||
| Cytoplasmic RNA from normal and malignant human cells shows homology to the DNAs of Epstein-Barr virus and human adenoviruses | Q33933857 | ||
| Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference | Q35129086 | ||
| Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA | Q35235890 | ||
| Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells | Q35237822 | ||
| Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells | Q35237835 | ||
| Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis | Q35238352 | ||
| Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line | Q35335767 | ||
| Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping | Q36390998 | ||
| Epstein-Barr Virus-Specific RNA III. Mapping of DNA Encoding Viral RNA in Restringent Infection | Q36491336 | ||
| Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line | Q36507642 | ||
| Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells | Q36542435 | ||
| DNA of herpesvirus pan, a third member of the Epstein-Barr virus-Herpesvirus papio group | Q36596456 | ||
| Random subcloning of sonicated DNA: application to shotgun DNA sequence analysis. | Q36597562 | ||
| Automation of the computer handling of gel reading data produced by the shotgun method of DNA sequencing | Q36649433 | ||
| Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein | Q36893502 | ||
| RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected, growth-transformed cells | Q36905838 | ||
| Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcr | Q36908739 | ||
| Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion | Q36924224 | ||
| Long internal direct repeat in Epstein-Barr virus DNA | Q36925615 | ||
| Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections | Q36925687 | ||
| Identification and nucleotide sequences of two similar tandem direct repeats in Epstein-Barr virus DNA | Q36927503 | ||
| One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain | Q37349287 | ||
| Expression of Epstein-Barr virus (EBV) DNA and cloned DNA fragments in human lymphocytes following Sendai virus envelope-mediated gene transfer | Q37569575 | ||
| A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection | Q37577729 | ||
| Homologous upstream sequences near Epstein-Barr virus promoters. | Q37606220 | ||
| Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro | Q37608005 | ||
| A new tumour-derived transforming strain of Epstein–Barr virus | Q40141830 | ||
| Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region | Q40142296 | ||
| Immunofluorescence and Herpes-Type Virus Particles in the P3HR-1 Burkitt Lymphoma Cell Line | Q40706383 | ||
| Simple Repeat Array in Epstein-Barr Virus DNA Encodes Part of the Epstein-Barr Nuclear Antigen | Q45798369 | ||
| Induction and biological characterization of the Epstein-Barr virus (EBV) carried by the Jijoye lymphoma line | Q45803853 | ||
| Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines | Q45826585 | ||
| Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line | Q45893613 | ||
| Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses | Q53580928 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| Epstein–Barr virus | Q6900 | ||
| P304 | page(s) | 7632-7636 | |
| P577 | publication date | 1984-12-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2 | |
| P478 | volume | 81 |
| Q36829470 | 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael |
| Q27683527 | A Molecular Basis for the Interplay between T Cells, Viral Mutants, and Human Leukocyte Antigen Micropolymorphism |
| Q36886069 | A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes |
| Q37175014 | A region of herpes simplex virus VP16 can substitute for a transforming domain of Epstein-Barr virus nuclear protein 2 |
| Q36854742 | A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein |
| Q36424931 | A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma |
| Q45783847 | A strategy for precision of genotyping of Epstein-Barr virus by polymerase chain reaction: application for studying Hodgkin's lymphoma |
| Q37531595 | A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus |
| Q35207078 | Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand |
| Q39601084 | Amino acids of Epstein-Barr virus nuclear antigen 3A essential for repression of Jkappa-mediated transcription and their evolutionary conservation |
| Q36820857 | An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator |
| Q41757439 | An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3) |
| Q36812687 | An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants |
| Q28370646 | An examination of the steric effects of 5-tert-butylproline on the conformation of polyproline and the cooperative nature of type II to type I helical interconversion |
| Q45876102 | Anti-Epstein-Barr virus-nuclear antigen-1, -2A and -2B antibodies in rheumatoid arthritis patients and their relatives |
| Q33931549 | Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen |
| Q44167647 | B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV). |
| Q33552058 | BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins |
| Q36919438 | Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection |
| Q33880983 | Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter |
| Q33998709 | C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7. |
| Q40883667 | CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation |
| Q24796759 | CODEHOP-mediated PCR - a powerful technique for the identification and characterization of viral genomes |
| Q45358262 | Characterization of Epstein-Barr virus (EBV) BZLF1 gene promoter variants and comparison of cellular gene expression profiles in Japanese patients with infectious mononucleosis, chronic active EBV infection, and EBV-associated hemophagocytic lymphoh |
| Q38950960 | Characterization of Epstein-Barr virus-encoded small RNA gene variations in virus associated lymphomas in Northern China |
| Q37393191 | Characterization of two related Epstein-Barr virus-encoded membrane proteins that are differentially expressed in Burkitt lymphoma and in vitro-transformed cell lines |
| Q40835517 | Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children |
| Q37111825 | Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia |
| Q56979156 | Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand e |
| Q35463816 | Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray |
| Q38808086 | Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences |
| Q42048053 | Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy |
| Q35835726 | Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk |
| Q40042560 | Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element |
| Q42068985 | Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants |
| Q39876670 | Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein-Barr virus variants |
| Q39589275 | Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains |
| Q37393138 | Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family |
| Q36828413 | Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression |
| Q43443832 | Detection of Epstein-Barr virus DNA in anal scrapings from HIV-positive homosexual men. |
| Q45743478 | Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children |
| Q41248404 | Detection of a nuclear antigen 2 (EBNA2)-variant Epstein-Barr virus strain in two siblings with fatal lymphoproliferative disease |
| Q45844566 | Detection of a second widespread strain of Epstein-Barr virus |
| Q37069836 | Development of a recombinant enzyme-linked immunosorbent assay for detection of antibodies against Epstein-Barr virus nuclear antigens 2A and 2B |
| Q45840383 | Development of cell systems to study viral gene transcription at the initial phase of Epstein-Barr virus infection |
| Q33929593 | Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells |
| Q39982347 | Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2. |
| Q41119648 | Direct identification by PCR of EBV types and variants in clinical samples |
| Q36781303 | Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. |
| Q35586544 | Distribution, persistence and interchange of Epstein-Barr virus strains among PBMC, plasma and saliva of primary infection subjects |
| Q38318791 | EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. |
| Q37093792 | EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance |
| Q38597233 | EBNA2 and Its Coactivator EBNA-LP. |
| Q57186827 | EBNA2: A Viral Transcription Factor Essential for the Immortalization of Human B Lymphocytes by the Epstein-Barr Virus (EBV) |
| Q38596333 | EBV-Specific Immune Response: Early Research and Personal Reminiscences |
| Q45840539 | Effect of activation of the Epstein-Barr virus genome on expression of B cell differentiation antigens of Burkitt's lymphoma lines |
| Q41709531 | Effect of transforming growth factor-beta 1 and -beta 2 on the proliferation of Burkitt lymphoma and lymphoblastoid cell lines |
| Q39284101 | Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL). |
| Q33782872 | Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort |
| Q36863075 | Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis |
| Q35228016 | Epstein-Barr Virus Based Expression Vectors |
| Q44251662 | Epstein-Barr Virus Gene Expression in Lymphoproliferative Disease |
| Q35225867 | Epstein-Barr Virus In B Lymphocytes: Viral Gene Expression and Function in Latency |
| Q38596335 | Epstein-Barr Virus Strain Variation |
| Q59354936 | Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice |
| Q28074586 | Epstein-Barr Virus: Diseases Linked to Infection and Transformation |
| Q38596342 | Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Types. |
| Q36653989 | Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. |
| Q34366291 | Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells |
| Q35586187 | Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan |
| Q45728468 | Epstein-Barr virus (EBV)-related oral squamous cell carcinoma in Okinawa, a subtropical island, in southern Japan--simultaneously infected with human papillomavirus (HPV). |
| Q45730963 | Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infection. |
| Q45722976 | Epstein-Barr virus DNA is detected in peripheral blood mononuclear cells of EBV-seronegative infants with infectious mononucleosis-like symptoms |
| Q38211091 | Epstein-Barr virus and rheumatoid arthritis: cellular and molecular aspects |
| Q45752122 | Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders |
| Q45770772 | Epstein-Barr virus in Hodgkin's disease patients in Japan |
| Q45763269 | Epstein-Barr virus in gastric carcinoma in Suzhou, China and Osaka, Japan: association with clinico-pathologic factors and HLA-subtype |
| Q45760027 | Epstein-Barr virus in malignancies in renal transplant recipients in Japan |
| Q45771539 | Epstein-Barr virus in non-Hodgkin's lymphomas and lymphoid tissue in children |
| Q36530296 | Epstein-Barr virus in oral diseases |
| Q35008870 | Epstein-Barr virus in the pathogenesis of NPC. |
| Q36464527 | Epstein-Barr virus infection at mucosal surfaces: detection of genomic variants with altered pathogenic potential |
| Q36637806 | Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. |
| Q35665981 | Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation |
| Q37319836 | Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2. |
| Q24681418 | Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1 |
| Q34324039 | Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation |
| Q36689004 | Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation |
| Q36621820 | Epstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation |
| Q36686055 | Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. |
| Q33891606 | Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia |
| Q64118196 | Epstein-Barr virus strain variation and cancer |
| Q38901360 | Epstein-Barr virus strains and variations: Geographic or disease-specific variants? |
| Q35115666 | Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. |
| Q44201416 | Epstein-Barr virus type B in patient with T-cell lymphoma |
| Q36782491 | Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes |
| Q36873046 | Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. |
| Q41697106 | Epstein-Barr virus: biology and disease. |
| Q38968588 | Epstein-Barr virus: more than 50 years old and still providing surprises. |
| Q42270427 | Epstein-barr virus diversity in immunocompetent healthy persons: reassessment of the distribution of genetic variants |
| Q33640115 | Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. |
| Q27003183 | Epstein-barr virus sequence variation-biology and disease |
| Q39596445 | Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus |
| Q45858982 | Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells |
| Q36865083 | Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells |
| Q41649264 | Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen |
| Q35865462 | Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals |
| Q40116177 | Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication |
| Q45326308 | Genome-wide analysis of Epstein-Barr virus identifies variants and genes associated with gastric carcinoma and population structure |
| Q45779973 | Genotypic analysis of Epstein-Barr virus associated with nasopharyngeal carcinoma of Japanese patients |
| Q30452144 | HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2 |
| Q41731609 | Herpesviruses and periodontopathic bacteria in Trisomy 21 periodontitis |
| Q37587096 | High molecular weight complex analysis of Epstein-Barr virus Latent Membrane Protein 1 (LMP-1): structural insights into LMP-1's homo-oligomerization and lipid raft association |
| Q33647633 | High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations |
| Q37737223 | Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses |
| Q37554196 | Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1. |
| Q40131194 | Identification and mapping of Epstein-Barr virus early antigens and demonstration of a viral gene activator that functions in trans |
| Q39684889 | Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay |
| Q35865306 | Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences |
| Q36231550 | Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies |
| Q35873998 | Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus. |
| Q36441745 | Immortalizing Genes of Epstein-Barr Virus |
| Q36669953 | Immune regulation in Epstein-Barr virus-associated diseases |
| Q36714426 | Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis |
| Q36863868 | Induction of Epstein-Barr virus nuclear antigens |
| Q40116431 | Induction of anti-EBNA-1 protein by 12-O-tetradecanoylphorbol-13-acetate treatment of human lymphoblastoid cells |
| Q40132148 | Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells |
| Q35865472 | Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals |
| Q40011755 | Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes |
| Q36231451 | Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development |
| Q40471906 | MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. |
| Q40129024 | Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines. |
| Q54269889 | Malignant neoplasm in kidney transplantation. |
| Q44572833 | Mammalian viruses in human periodontitis |
| Q36919476 | Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector |
| Q41718399 | Modulation of cellular gene expression in B lymphoma cells followingin vitro infection by Epstein-Barr virus (EBV) |
| Q33772225 | Molecular evolution of the gamma-Herpesvirinae |
| Q36920279 | Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines |
| Q35785286 | Multiple roles of Epstein-Barr virus SM protein in lytic replication |
| Q36000904 | Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1). |
| Q33841899 | Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parameters and tumorigenicity in SCID and nude mice |
| Q34299744 | Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes |
| Q36511890 | Nasal NK/T-cell lymphoma: epidemiology and pathogenesis |
| Q37611115 | Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies |
| Q39588391 | Novel intertypic recombinants of epstein-barr virus in the chinese population |
| Q48040715 | Nucleotide sequence analysis of a 30-kilobase-pair region of human herpesvirus-6B (HHV-6B) genome and strain-specific variations in major immediate-early genes |
| Q35616566 | Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site |
| Q44035282 | Oligopeptide Induction of a Secondary Cytotoxic T-cell Response to Epstein-Barr Virus In Vitro |
| Q59358045 | Phylogenetic comparison of Epstein-Barr virus genomes |
| Q36883713 | Promiscuous trans activation of gene expression by an Epstein-Barr virus-encoded early nuclear protein |
| Q36407109 | Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines |
| Q33880494 | Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells |
| Q36690443 | Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection |
| Q33795078 | Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses |
| Q45873907 | Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus |
| Q38291833 | Sporadic activation of Epstein-Barr virus in thyroid lymphoma |
| Q36801839 | Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. |
| Q35879835 | Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate |
| Q45748463 | Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope |
| Q33816120 | Target DNA detection and quantitation on a single cell with single base resolution |
| Q35664999 | The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation |
| Q36635773 | The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. |
| Q34341875 | The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenance |
| Q30278553 | The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment |
| Q36637817 | The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. |
| Q36581891 | The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein |
| Q34355226 | The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter |
| Q39216150 | The Epstein-Barr virus proteins |
| Q35859057 | The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation. |
| Q35999054 | The analysis of EBV proteins which are antigenic in vivo |
| Q34089485 | The expression and function of Epstein-Barr virus encoded latent genes |
| Q37549340 | The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal |
| Q40310879 | The genetic diversity of Epstein-Barr virus in the setting of transplantation relative to non-transplant settings: A feasibility study. |
| Q45419603 | The genome of Epstein-Barr virus type 2 strain AG876. |
| Q34327455 | The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. |
| Q36806641 | The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization |
| Q43903283 | The molecular genetics of post-transplantation lymphoproliferative disorders |
| Q39755299 | The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene |
| Q34798881 | The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas |
| Q28298372 | Topics in herpesvirus genomics and evolution |
| Q36903105 | Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H |
| Q40100585 | Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. |
| Q36697392 | Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro |
| Q41350801 | Vaccination against Epstein-Barr virus: current progress and future strategies |
| Q40175717 | Variation of DNA sequence in immediate-early gene of human herpesvirus 6 and variant identification by PCR. |
| Q44345035 | Viruses and cancer risks: outgrowth of Epstein-Barr virus-positive Burkitt's lymphoma in the immune host |
| Q34353358 | cdc2/cyclin B1-dependent phosphorylation of EBNA2 at Ser243 regulates its function in mitosis |
Search more.